Matthias Schönermark

from Wikipedia, the free encyclopedia

Matthias P. Schönermark (born February 19, 1964 in Essen ) is a German ENT doctor , university professor , management consultant and coach .

Life

As the son of a head doctor in Öhringen , Schönermark joined the army (Bundeswehr) after graduating from high school . Dismissed as a lieutenant , he went on to study general studies at the Ludwig Maximilians University in Munich in 1984/85 . He switched to the Georg-August University in Göttingen to study medicine . In 1984 he became a member of the Corps Isaria and 1985 of the Corps Hannovera Göttingen . He did the Physikum 1986 in Munich. He completed the clinical part of his studies at the Ruprecht-Karls-Universität Heidelberg , the University of London and the University of Cape Town . He received his doctorate in 1991 for Dr. med. and has worked as a postgraduate at Columbia University and Dartmouth Medical School in Hanover, NH, among others . He became a specialist in ear, nose and throat medicine in 1997 at the Hannover Medical School (MHH) .

After completing his habilitation in 1998 , he joined the Boston Consulting Group . In 2001/02 he was CEO at MWG-Biotech . After an interlude as Associate Director at AT Kearney , he founded Schönermark Kielhorn Collegen (SKC) Beratungsgesellschaft mbH in 2004 , where he works as a managing partner. Schönermark is a member of the supervisory boards of DOREA GmbH and HeartGenetics, Genetics & Biotechnology, SA.

Since 2000 professor for medical management at the MHH, he founded the Hannover School of Health Management (HSHM). He teaches strategic management at US and European universities . In 2015 he qualified as a systemic therapist.

Schönermark has published over 300 publications in scientific journals and the general press. The core topics are molecular oncology , cancer research , strategy , health management , HTA (Health Technology Assessment) , leadership and digital health.

Schönermark is married and has five children. As a volunteer, he is a member of the Board of Trustees for the Center for Biomedical Technology and Innovation, BiomeTI Hanover and the steering committee of the future workshop GKV.

Publications (selection)

  • Human glomerular mesangial cells. Cultivation, characterization and interactions with inflammation mediators , 1991 (PhD thesis).
  • The influence of retinoid acid on the molecular mechanisms of metalloproteinase-mediated matrix degradation and tumor invasion , 1997 (habilitation thesis).

Web links

Individual evidence

  1. ↑ SKC Consulting Company - Management. In: skc-beratung.de. SKC Consulting Company, accessed April 17, 2018 .
  2. ^ Xing - Coaches & Trainers. In: Xing. Xing, accessed on April 17, 2018 .
  3. ↑ Kösener Corpslisten 1996, 82/1560; 59/1315
  4. ↑ Manager Magazin
  5. ↑ SKC
  6. ↑ DOREA family - companies. In: doreafamilie.de. DOREA GmbH, accessed on April 17, 2018 .
  7. ↑ Heart Genetics - Advisory Board. In: heartgenetics.com. HeartGenetics, Genetics & Biotechnology, SA, accessed April 17, 2018 .
  8. ↑ Medical management MHH
  9. ↑ HSHM
  10. ↑ BiomeTI
  11. ↑ Future workshop GKV (PDF; 66 kB)
personal data
SURNAME Schönermark, Matthias
ALTERNATIVE NAMES Schönermark, Matthias P.
BRIEF DESCRIPTION German ENT doctor, university professor, management consultant and coach
DATE OF BIRTH 19th February 1964
PLACE OF BIRTH eat